journal article Dec 01, 2020

A Phase 2 Open-Label Study to Evaluate VP-102 for the Treatment of Molluscum Contagiosum

Sahra Niazi Bradford Brabec Luke Anschutz Cynthia Willson Matthew Davidson

Patrick Burnett

Journal of Drugs in Dermatology Vol. 20 No. 1 pp. 70-75 · SanovaWorks

View at Publisher Save 10.36849/jdd.5626

Topics

No keywords indexed for this article. Browse by subject →

Metrics

7

Citations

0

References

Details

Published: Dec 01, 2020
Vol/Issue: 20(1)
Pages: 70-75

Authors

Bradford Brabec

Cynthia Willson

Matthew Davidson

Patrick Burnett

Cite This Article

Sahra Niazi, Bradford Brabec, Luke Anschutz, et al. (2020). A Phase 2 Open-Label Study to Evaluate VP-102 for the Treatment of Molluscum Contagiosum. Journal of Drugs in Dermatology, 20(1), 70-75. https://doi.org/10.36849/jdd.5626

Related

You May Also Like

Molluscum Contagiosum Virus Evasion of Immune Surveillance: A Review

Haowei Han, Ciaran Smythe · 2023

12 citations

A Retrospective Comparative Analysis of Cutaneous Adverse Reactions in GLP-1 Agonist Therapies

Sophia Daniel, Stephanie Waggett · 2025

11 citations

Pharmacokinetic Profile, Safety, and Tolerability of Topical Berdazimer Gel, 10.3% in Patients With Molluscum Contagiosum

Martina Cartwright, Carolyn Enloe · 2022

9 citations

Gene Analysis of Biostimulators: Poly-L-Lactic Acid Triggers Regeneration While Calcium Hydroxylapatite Induces Inflammation Upon Facial Injection

Jill Waibel, Thu Q. Nguyen · 2024

9 citations

Early Response is Associated With Stable Long-Term Response in Psoriasis Patients Receiving Ixekizumab or Ustekinumab

Mathias Augustin, Gaia Gallo · 2022

9 citations